EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the adjuvant treatment after tumour resection of patients with epidermal growth factor receptor- mutation-positive (EGFRm) non-small cell lung cancer (NSCLC). L'invention concerne d...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MANN, Helen BORELLINI, Flavia RUKAZENKOV, Yuri GHIORGHIU, Serban |
| description | The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the adjuvant treatment after tumour resection of patients with epidermal growth factor receptor- mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).
L'invention concerne des inhibiteurs de tyrosine kinase (TKI) du récepteur du facteur de croissance épidermique (EGFR), destinés à être utilisés dans le traitement adjuvant après résection tumorale de patients atteints d'un cancer du poumon non à petites cellules (CPNPC) positif aux mutations du récepteur du facteur de croissance épidermique (EGFRm). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021239786A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021239786A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021239786A13</originalsourceid><addsrcrecordid>eNrjZHBwdXcLUgjx9gxWcPMPUggNdlXw9FMI8XBVCAlydQzxdfULUfB3U_Dz99MN9nX08VFwdgUSPqF-7grOjn7OrkE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-3N_IwMjQyNjS3MLM0dCYOFUADskrDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER</title><source>esp@cenet</source><creator>MANN, Helen ; BORELLINI, Flavia ; RUKAZENKOV, Yuri ; GHIORGHIU, Serban</creator><creatorcontrib>MANN, Helen ; BORELLINI, Flavia ; RUKAZENKOV, Yuri ; GHIORGHIU, Serban</creatorcontrib><description>The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the adjuvant treatment after tumour resection of patients with epidermal growth factor receptor- mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).
L'invention concerne des inhibiteurs de tyrosine kinase (TKI) du récepteur du facteur de croissance épidermique (EGFR), destinés à être utilisés dans le traitement adjuvant après résection tumorale de patients atteints d'un cancer du poumon non à petites cellules (CPNPC) positif aux mutations du récepteur du facteur de croissance épidermique (EGFRm).</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211202&DB=EPODOC&CC=WO&NR=2021239786A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211202&DB=EPODOC&CC=WO&NR=2021239786A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MANN, Helen</creatorcontrib><creatorcontrib>BORELLINI, Flavia</creatorcontrib><creatorcontrib>RUKAZENKOV, Yuri</creatorcontrib><creatorcontrib>GHIORGHIU, Serban</creatorcontrib><title>EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER</title><description>The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the adjuvant treatment after tumour resection of patients with epidermal growth factor receptor- mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).
L'invention concerne des inhibiteurs de tyrosine kinase (TKI) du récepteur du facteur de croissance épidermique (EGFR), destinés à être utilisés dans le traitement adjuvant après résection tumorale de patients atteints d'un cancer du poumon non à petites cellules (CPNPC) positif aux mutations du récepteur du facteur de croissance épidermique (EGFRm).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHBwdXcLUgjx9gxWcPMPUggNdlXw9FMI8XBVCAlydQzxdfULUfB3U_Dz99MN9nX08VFwdgUSPqF-7grOjn7OrkE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-3N_IwMjQyNjS3MLM0dCYOFUADskrDg</recordid><startdate>20211202</startdate><enddate>20211202</enddate><creator>MANN, Helen</creator><creator>BORELLINI, Flavia</creator><creator>RUKAZENKOV, Yuri</creator><creator>GHIORGHIU, Serban</creator><scope>EVB</scope></search><sort><creationdate>20211202</creationdate><title>EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER</title><author>MANN, Helen ; BORELLINI, Flavia ; RUKAZENKOV, Yuri ; GHIORGHIU, Serban</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021239786A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MANN, Helen</creatorcontrib><creatorcontrib>BORELLINI, Flavia</creatorcontrib><creatorcontrib>RUKAZENKOV, Yuri</creatorcontrib><creatorcontrib>GHIORGHIU, Serban</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MANN, Helen</au><au>BORELLINI, Flavia</au><au>RUKAZENKOV, Yuri</au><au>GHIORGHIU, Serban</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER</title><date>2021-12-02</date><risdate>2021</risdate><abstract>The specification relates to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for use in the adjuvant treatment after tumour resection of patients with epidermal growth factor receptor- mutation-positive (EGFRm) non-small cell lung cancer (NSCLC).
L'invention concerne des inhibiteurs de tyrosine kinase (TKI) du récepteur du facteur de croissance épidermique (EGFR), destinés à être utilisés dans le traitement adjuvant après résection tumorale de patients atteints d'un cancer du poumon non à petites cellules (CPNPC) positif aux mutations du récepteur du facteur de croissance épidermique (EGFRm).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021239786A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A22%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MANN,%20Helen&rft.date=2021-12-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021239786A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |